Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease

Item

http://www.wikidata.org/entity/Q35791729

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease

@ast

Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease

@en

type

Item

label

Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease

@ast

Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease

@en

prefLabel

Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease

@ast

Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease

@en

P1476

Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease

@en

P2093

Atsushi Kosaki

http://www.w3.org/2001/XMLSchema#string

Eiko Matsuoka

http://www.w3.org/2001/XMLSchema#string

Hiroaki Matsubara

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kado

http://www.w3.org/2001/XMLSchema#string

Keiichi Tamagaki

http://www.w3.org/2001/XMLSchema#string

Kumiko Iida

http://www.w3.org/2001/XMLSchema#string

Masato Nishimura

http://www.w3.org/2001/XMLSchema#string

Noboru Maki

http://www.w3.org/2001/XMLSchema#string

Noriko Kishimoto

http://www.w3.org/2001/XMLSchema#string

Noriyuki Iwamoto

http://www.w3.org/2001/XMLSchema#string

P2860

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

The biology of the receptor for advanced glycation end products and its ligands.

Inflammatory and atherosclerotic interactions in the depleted uremic patient.

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients

ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, S

Vascular remodeling and arterial calcification are directly mediated by S100A12 (EN-RAGE) in chronic kidney disease.

Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients.

P304

242-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000335198

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223982986

http://www.w3.org/2001/XMLSchema#string

P698

22470398

http://www.w3.org/2001/XMLSchema#string

P932

3290833

http://www.w3.org/2001/XMLSchema#string